Keyphrases
Peroxisome Proliferator-activated Receptor
100%
Cell Maturation
100%
Oligodendrocyte Precursor Cells
100%
Bone Morphogenetic Protein
100%
Progenitor Cells
62%
GW0742
62%
Experimental Autoimmune Encephalomyelitis
37%
Peroxisome Proliferator-activated Receptor Agonists
37%
Astrocytes
25%
MRNA Level
12%
Protein Expression
12%
Cell-derived
12%
Clinical Benefit
12%
Myelin
12%
Null Mice
12%
Process Formation
12%
Bone Morphogenetic protein-2 (BMP-2)
12%
Bone Morphogenetic Protein 4 (BMP4)
12%
Oligodendrocyte Maturation
12%
Pioglitazone
12%
Astrocyte Culture
12%
Clinical Score
12%
Noggin Protein
12%
Bone Morphogenetic Protein Antagonist
12%
Myelin Gene Expression
12%
Noggin
12%
Neuroscience
Cell Maturation
100%
Progenitor Cell
100%
Oligodendrocyte Progenitor
100%
Bone Morphogenetic Protein
100%
Peroxisome Proliferator-Activated Receptor
100%
Experimental Autoimmune Encephalomyelitis
37%
Astrocyte
37%
PPAR Agonist
37%
Myelin
25%
Noggin
25%
Agonist
12%
Protein Expression
12%
Gene Expression
12%
Oligodendrocyte
12%
Bone Morphogenetic Protein 2
12%
Pioglitazone
12%
Bone Morphogenetic Protein 4
12%
Pharmacology, Toxicology and Pharmaceutical Science
Peroxisome Proliferator Activated Receptor
100%
Bone Morphogenetic Protein
100%
[4 [2 (3 Fluoro 4 Trifluoromethylphenyl) 4 Methyl 5 Thiazolylmethylthio] 2 Methylphenoxy]acetic Acid
62%
Experimental Autoimmune Encephalomyelitis
37%
PPAR Agonist
37%
Myelin
25%
Noggin
25%
Mouse
12%
Knockout Mouse
12%
Bone Morphogenetic Protein 4
12%
Pioglitazone
12%
Bone Morphogenetic Protein 2
12%